T 1094/10 (Double stranded RNA modified 2'O-Methyl aligned phase shift pattern/SILENCE THERAPEUTICS) of 11.02.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T109410.20150211
- Date of decision
- 11 February 2015
- Case number
- T 1094/10
- Online on
- 20 March 2015
- Petition for review of
- -
- Application number
- 03784183.0
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- FURTHER NOVEL FORMS OF INTERFERING RNA MOLECULES
- Applicant name
- Silence Therapeutics GmbH
- Opponent name
- ALCON LABORATORIES, INC.
Sirna Therapeutics
Grund, Martin, Dr.
Alnylam Pharmaceuticals Inc. - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 84European Patent Convention Art 83European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 12(4)European Patent Convention Art 54
- Keywords
- Main Request - admissibility (yes);
Main Request - requirements of the EPC met (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent with claims 1 - 12 of the Main Request received during oral proceedings of 11 February 2015 and a description to be adapted.